Systemic treatment of advanced basal cell carcinoma: how to critically evaluate value for patient and society?

Ther Adv Med Oncol. 2022 Dec 13:14:17588359221141762. doi: 10.1177/17588359221141762. eCollection 2022.

Authors

Isabelle Hoorens^{1

2}, Laura Van Coile^{1

2}, Celine Jacobs³, Michael Saerens³, Evelien Verhaeghe^{1

2}, Lieve Brochez⁴

Affiliations

¹ Department of Dermatology, University Hospital Ghent, Ghent, Belgium.
² Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
³ Department of Medical Oncology, University Hospital Ghent, Ghent, Belgium.
⁴ Department of Dermatology, University Hospital Ghent, Corneel Heymanslaan 10, Ghent 9000, Belgium.

No abstract available

Keywords: QALY; advanced basal cell carcinoma; anti-PD-1; hedgehog pathway inhibitor; value-based health care.

Publication types

Editorial